302 related articles for article (PubMed ID: 36594473)
1. Targeting fatty acid metabolism in glioblastoma.
Miska J; Chandel NS
J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594473
[TBL] [Abstract][Full Text] [Related]
2. Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.
Papavassiliou KA; Papavassiliou AG
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188667. PubMed ID: 34894431
[TBL] [Abstract][Full Text] [Related]
3. Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment.
Lee H; Kim D; Youn B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430293
[TBL] [Abstract][Full Text] [Related]
4. The role of Stat3 in glioblastoma multiforme.
Luwor RB; Stylli SS; Kaye AH
J Clin Neurosci; 2013 Jul; 20(7):907-11. PubMed ID: 23688441
[TBL] [Abstract][Full Text] [Related]
5. AKT/GSK3β Signaling in Glioblastoma.
Majewska E; Szeliga M
Neurochem Res; 2017 Mar; 42(3):918-924. PubMed ID: 27568206
[TBL] [Abstract][Full Text] [Related]
6. Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma.
Drakulic D; Schwirtlich M; Petrovic I; Mojsin M; Milivojevic M; Kovacevic-Grujicic N; Stevanovic M
Cells; 2022 Aug; 11(16):. PubMed ID: 36010607
[TBL] [Abstract][Full Text] [Related]
7. The Multifaceted Metabolism of Glioblastoma.
Quinones A; Le A
Adv Exp Med Biol; 2018; 1063():59-72. PubMed ID: 29946775
[TBL] [Abstract][Full Text] [Related]
8. New Directions in the Treatment of Glioblastoma.
Reitman ZJ; Winkler F; Elia AEH
Semin Neurol; 2018 Feb; 38(1):50-61. PubMed ID: 29548052
[TBL] [Abstract][Full Text] [Related]
9. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
Wang G; Wang J; Zhao H; Wang J; Tony To SS
Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
[TBL] [Abstract][Full Text] [Related]
10. Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence.
Mecca C; Giambanco I; Donato R; Arcuri C
Dis Markers; 2018; 2018():9230479. PubMed ID: 30662577
[TBL] [Abstract][Full Text] [Related]
11. Necroptosis: a novel therapeutic target for glioblastoma.
Jiang YG; Peng Y; Koussougbo KS
Med Hypotheses; 2011 Mar; 76(3):350-2. PubMed ID: 21075544
[TBL] [Abstract][Full Text] [Related]
12. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.
Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C
Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686
[TBL] [Abstract][Full Text] [Related]
13. Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment.
Kant S; Kesarwani P; Prabhu A; Graham SF; Buelow KL; Nakano I; Chinnaiyan P
Cell Death Dis; 2020 Apr; 11(4):253. PubMed ID: 32312953
[TBL] [Abstract][Full Text] [Related]
14. The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment.
Guo G; Narayan RN; Horton L; Patel TR; Habib AA
Curr Cancer Drug Targets; 2017; 17(3):297-302. PubMed ID: 28004613
[TBL] [Abstract][Full Text] [Related]
15. Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies.
Legendre C; Garcion E
Trends Endocrinol Metab; 2015 Jun; 26(6):322-31. PubMed ID: 25936466
[TBL] [Abstract][Full Text] [Related]
16. Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma.
Jayaram S; Gupta MK; Raju R; Gautam P; Sirdeshmukh R
OMICS; 2016 Dec; 20(12):736-746. PubMed ID: 27930095
[TBL] [Abstract][Full Text] [Related]
17. Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme.
England B; Huang T; Karsy M
Tumour Biol; 2013 Aug; 34(4):2063-74. PubMed ID: 23737287
[TBL] [Abstract][Full Text] [Related]
18. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Zhang H; Zhou Y; Cui B; Liu Z; Shen H
Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
[TBL] [Abstract][Full Text] [Related]
19. PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells.
Udawant S; Litif C; Lopez A; Gunn B; Schuenzel E; Keniry M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831287
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma.
Tompa M; Kalovits F; Nagy A; Kalman B
Neuromolecular Med; 2018 Dec; 20(4):437-451. PubMed ID: 30259273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
